Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain

Journal of Neuroscience

Volumn 34, Issue 7, 2014, Pages 2503-2513

  Campbell, Iain L ^a   Erta, Maria ^b   Lim, Sue Ling ^a   Frausto, Ricardo ^a   May, Ulrike ^c   Rose John, Stefan ^c   Scheller, Jürgen ^d   Hidalgo, Juan ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF KIEL   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Interleukin 6; Neuropathology; Signal transduction; Trans signaling; Transgenic mouse

Indexed keywords

INTERLEUKIN-6; NEUROPATHOLOGY; SIGNAL TRANSDUCTION; TRANS-SIGNALING; TRANSGENIC MOUSE;

ANIMALS; BRAIN; CYTOKINE RECEPTOR GP130; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTERLEUKIN-6; MICE; MICE, TRANSGENIC; SIGNAL TRANSDUCTION;

EID: 84893676729     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2830-13.2014     Document Type: Article

References (46)

1. Auernhammer CJ, Bousquet C, Melmed S (1999) Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A 96:6964-6969. CrossRef Medline
2. Brett FM, Mizisin AP, Powell HC, Campbell IL (1995) Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 54:766-775. CrossRef Medline
3. Brunello AG, Weissenberger J, Kappeler A, Vallan C, Peters M, Rose-John S, Weis J (2000) Astrocytic alterations in interleukin-6/soluble interleukin-6 receptor alpha double-transgenic mice. Am J Pathol 157:1485-1493. CrossRef Medline
4. Burton MD, Sparkman NL, Johnson RW (2011) Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharideinduced sickness behavior. J Neuroinflammation 8:54. CrossRef Medline
5. Burton MD, Rytych JL, Freund GG, Johnson RW (2013) Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice. Brain Behav Immun 30:66-72. CrossRef Medline
6. Campbell IL (1998) Structural and functional impact of the transgenic expression of cytokines in the CNS. Ann N Y Acad Sci 840:83-96. CrossRef Medline
7. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L (1993) Neurologic disease induced in transgenic mice by the cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A 90: 10061-10065. CrossRef Medline
8. Campbell IL, Hofer MJ, Pagenstecher A (2010) Transgenic models for cytokine-induced neurological disease. Biochim Biophys Acta 1802:903-917. CrossRef Medline
9. Cassatella MA, Gasperini S, Bovolenta C, Calzetti F, Vollebregt M, Scapini P, Marchi M, Suzuki R, Suzuki A, Yoshimura A (1999) Interleukin-10 (IL-10) selectively enhanced CIS3/SOCS3 m RNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 94:2880-2889. Medline
10. Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, Fielding CA, Jones SA, Rose-John S, Scheller J (2007) Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 110:1748-1755. CrossRef Medline
11. Chiang CS, Stalder A, Samimi A, Campbell IL (1994) Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev Neurosci 16:212-221. CrossRef Medline
12. Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O (2003) Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A 100:13632-13637. CrossRef Medline
13. Fee D, Grzybicki D, Dobbs M, Ihyer S, Clotfelter J, Macvilay S, Hart MN, Sandor M, Fabry Z (2000) Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells. Cytokine 12:655-665. CrossRef Medline
14. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1-20. CrossRef Medline
15. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S, Sofroniew MV (2008) STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28:7231-7243. CrossRef Medline
16. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH (1997) Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A 94:1500-1505. CrossRef Medline
17. Holmberg KH, Patterson PH (2006) Leukemia inhibitory factor is a key regulator of astrocytic, microglial and neuronal responses in a low-dose pilocarpine injury model. Brain Res 1075:26-35. CrossRef Medline
18. Jostock T, Müllberg J, Ozbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S (2001) Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 268:160-167. CrossRef Medline
19. Kahn MA, Ellison JA, Speight GJ, de Vellis J (1995) CNTF regulation of astrogliosis and the activation of microglia in the developing rat central nervous system. Brain Res 685:55-67. CrossRef Medline
20. Levison SW, Hudgins SN, Crawford JL (1998) Ciliary neurotrophic factor stimulates nuclear hypertrophy and increases the GFAP content of cultured astrocytes. Brain Res 803:189-193. CrossRef Medline
21. Lin HW, Levison SW (2009) Context-dependent IL-6 potentiation of interferon-gamma-induced IL-12 secretion and CD40 expression in murine microglia. J Neurochem 111:808-818. CrossRef Medline
22. Lust JA, Donovan KA, Kline MP, Greipp PR, Kyle RA, Maihle NJ (1992) Isolation of an m RNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4:96-100. CrossRef Medline
23. Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S (1992) Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acutephase proteins. J Immunol 149:2021-2027. Medline
24. Maier J, Kincaid C, Pagenstecher A, Campbell IL (2002) Regulation of signal transducer and activator of transcription and suppressor of cytokine signaling gene expression in the brain of mice with astrocyte-targeted production of IL-12 and experimental autoimmune encephalomyelitis. Am J Pathol 160:271-288. CrossRef Medline
25. März P, Herget T, Lang E, Otten U, Rose-John S (1997a) Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur J Neurosci 9:2765-2773. CrossRef Medline
26. März P, Heese K, Hock C, Golombowski S, Müller-Spahn F, Rose-John S, Otten U (1997b) Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 239:29-32. CrossRef Medline
27. März P, Heese K, Dimitriades-Schmutz B, Rose-John S, Otten U (1999) Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia 26: 191-200. CrossRef Medline
28. Michalopoulou M, Nikolaou C, Tavernarakis A, Alexandri NM, Rentzos M, Chatzipanagiotou S, Cambouri C, Vassilopoulos D (2004) Soluble interleukin-6 receptor (s IL-6R) in cerebrospinal fluid of patients with inflammatory and noninflammatory neurological diseases. Immunol Lett 94:183-189. CrossRef Medline
29. Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760-1765. CrossRef Medline
30. Müllberg J, Schooltink H, Stoyan T, Günther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose-John S (1993) The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23:473-480. CrossRef Medline
31. Müllberg J, Vollmer P, Althoff K, März P, Rose-John S (1999) Generation and function of the soluble interleukin-6 receptor. Biochem Soc Trans 27:211-219. Medline
32. Nakanishi M, Niidome T, Matsuda S, Akaike A, Kihara T, Sugimoto H (2007) Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. Eur J Neurosci 25:649-658. CrossRef Medline
33. Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos GD, Taga T, Kishimoto T (1993) Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membraneanchored gp130. Blood 82:1120-1126. Medline
34. Rabe B, Chalaris A, May U, Waetzig GH, Seegert D, Williams AS, Jones SA, Rose-John S, Scheller J (2008) Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 111:1021-1028. CrossRef Medline
35. Röhl C, Sievers J (2005) Microglia is activated by astrocytes in trimethyltin intoxication. Toxicol Appl Pharmacol 204:36-45. CrossRef Medline
36. Rose-John S, Heinrich PC (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300:281-290. Medline
37. Rose-John S, Scheller J, Elson G, Jones SA (2006) Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80:227-236. CrossRef Medline
38. Ruifrok AC, Johnston DA (2001) Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23:291-299. Medline
39. Sanz E, Hofer MJ, Unzeta M, Campbell IL (2008) Minimal role for STAT1 in interleukin-6 signaling and actions in the murine brain. Glia 56:190-199. CrossRef Medline
40. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813:878-888. CrossRef Medline
41. Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, Haegeman G, Gerlo S (2011) Interleukin-6, a mental cytokine. Brain Res Rev 67:157-183. CrossRef Medline
42. Stalder A, Pagenstecher A, Kincaid C, Campbell IL (1999) Analysis of gene expression by multiprobe RNase protection assay. In: Neurodegeneration methods and protocols. (Harry J, Tilson HA, eds), pp 53-66. Totowa, NJ: Human.
43. Vallières L, Campbell IL, Gage FH, Sawchenko PE (2002) Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci 22:486-492. Medline
44. Van Wagoner NJ, Oh JW, Repovic P, Benveniste EN (1999) Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J Neurosci 19:5236-5244. Medline
45. Wang J, Schreiber RD, Campbell IL (2002) STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-α in the central nervous system. Proc Natl Acad Sci U S A 99:16209-16214. CrossRef Medline
46. Yao JS, Zhai W, Young WL, Yang GY (2006) Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9. Biochem Biophys Res Commun 342:1396-1404. CrossRef Medline